Miami CRO, Boston nonprofit team up to promote research in Colombia

Cartagena

Miami, FL’s Interventional Concepts has announced an initiative with the Alliance for Clinical Research Excellence and Safety aimed at bolstering research activities and standards in Colombia.

Under the deal, Interventional Concepts will help set up an ACRES national affiliate in Colombia through efforts with local academics, organizations and companies. The institution will then facilitate and encourage clinical research in the country. ACRES--a nonprofit based in Cambridge, MA--seeks to develop a “shared global system for safe, high-performance” trial work by incorporating lessons and practices learned from other industries in the clinical research space.

Interventional Concepts, which works with life sciences companies to conduct trial work in Colombia, says the country boasts a free trade agreement with the U.S. and a “predictable national regulatory pathway for clinical trials” that is the fastest in Latin America.

Virtual Event

Virtual Clinical Trials Online

This virtual event will bring together industry experts to discuss the increasing pace of pharmaceutical innovation, the need to maintain data quality and integrity as new technologies are implemented and understand regulatory challenges to ensure compliance.

The affiliate will work to ensure that Colombia's clinical trial quality, safety and ethical conduct is in line with global standards.

“Efforts to enhance clinical research capacity and quality in Latin America are very exciting, and Colombia has stepped forward to take a leading role. We are delighted to be working with our colleagues there since a global system only works if it embraces, mobilizes and unifies local resources,” ACRES CEO Greg Koski said in a statement.

With a population of 50 million in a universal healthcare system, Colombia shares a time zone with the U.S. east coast and has the healthcare and commercial environment suited for clinical work, Interventional Concepts said.

- here's the release

Pictured is the city of Cartagena in Colombia, courtesy of Norma Gòmez.

Suggested Articles

Millions of tests are urgently needed as the virus keeps communities across the country in lockdown and hospitals are overwhelmed with patients.

The FDA granted its first emergency authorization for a rapid antibody blood test for COVID-19 developed by Cellex.

Cancer biotech Zentalis Pharmaceuticals priced its IPO at $165 million, eclipsing the $100 million goal it laid out in early March.